Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil during rhinoplasty under general anesthesia
IRCT20250412065291N4Phase 3Recruiting
- Sponsor
- Ilam University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine and remifentanil (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoints: Hemodynamics, Bleeding rate and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on IRCT20250412065291N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250412065291N4.